Work

Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study

Year: 2020
Type: review
Study design: Observational Study
Abstract: Background and aims Apolipoprotein A-I (apoA-I) infusions represent a potential novel therapeutic approach for the prevention of coronary artery disease (CAD). Although circulating apoA-I concentrations inversely associate with risk of CAD, the evidence base of this representing a causal relationship is lacking. The aim was to assess the causal role of apoA-I using human genetics. Methods We identified a variant (rs12225230) in APOA1 locus that associated with circulating apoA-I concentrations ( p < 5 × 10 −8 ) in 20,370 Finnish participants, and meta-analyzed our data with a previous GWAS of apoA-I. We obtained genetic estimates of CAD from UK Biobank and CARDIoGRAMplusC4D (totaling 122,733 CAD cases) and conducted a two-sample Mendelian randomization analysis. We compared our genetic findings to observational associations of apoA-I with risk of CAD in 918 incident CAD cases among 11,535 individuals from population-based prospective cohorts. Results ApoA-I was associated with a lower risk of CAD in observational analyses (HR 0.81; 95%CI: 0.75, 0.88; per 1-SD higher apoA-I), with the association showing a dose-response relationship. Rs12225230 associated with apoA-I concentrations (per-C allele beta 0.076 SD; SE: 0.013; p = 1.5 × 10 −9 ) but not with confounders. In Mendelian randomization analyses, apoA-I was not related to risk of CAD (OR 1.13; 95%CI: 0.98,1.30 per 1-SD higher apoA-I), which was different from the observational association. Similar findings were observed using an independent ABCA1 variant in sensitivity analysis. Conclusions Genetic evidence fails to support a cardioprotective role for apoA-I. This is in line with the cumulative evidence showing that HDL-related phenotypes are unlikely to have a protective role in CAD.
Authors: Minna K. Karjalainen(Conceptualization, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing), Michael V. Holmes(Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing), Qin Wang(Conceptualization, Methodology, Writing – original draft, Writing – review & editing), Olga Anufrieva(Formal analysis, Investigation, Validation, Writing – review & editing), Mika Kähönen(Data curation, Resources, Writing – review & editing), Terho Lehtimäki(Data curation, Resources, Writing – review & editing), Aki S. Havulinna(Data curation, Resources, Writing – review & editing), Kati Kristiansson(Data curation, Resources, Writing – review & editing), Veikko Salomaa(Data curation, Resources, Writing – review & editing), Markus Perola(Data curation, Resources, Writing – review & editing), Jorma S. Viikari(Data curation, Resources, Writing – review & editing), Olli T. Raitakari(Data curation, Resources, Writing – review & editing), Marjo-Riitta Järvelin(Data curation, Resources, Writing – review & editing), Mika Ala-Korpela(Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing), Johannes Kettunen(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Genetics
Open Access status: hybrid
Estimated APC paid: $4,020
OpenAlex ID: W3006634014
FWCI: 1.443
Cites: 60
Cited by: 79
Related to: 9